Work

Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose)

Year: 2015

Type: article

Study design: Clinical Trial

Source: Eye

DOI: 10.1038/eye.2015.142

Authors: for the READ-3 Study Group, D V Do, Y J Sepah, D Boyer, D Callanan, R Gallemore, M Bennett, D M Marcus, L Halperin, M A Sadiq, N Rajagopalan, P A Campochiaro, Q D Nguyen

Institutions: University of Nebraska Medical Center, Retina Vitreous Associates Medical Group, Texas Retina Associates (United States), Retina Macula Institute, Retina Institute of Hawaii, Southeast Retina Center, Johns Hopkins University

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Juvenile Diabetes Research Foundation United States of America, Regeneron Pharmaceuticals, Santen, Genentech, Allergan

OpenAlex ID: W941553642

FWCI: 4.327

Cites: 7

Cited by: 43

Related to: 10